Misuse of FP10 Prescriptions – Mounjaro and Weight Loss Medications
Thursday 11th June 2026
A pattern of fraud has been identified involving the misuse of prescribing systems and paper FP10 prescriptions to obtain high-value weight loss medications, including Mounjaro (tirzepatide) and similar drugs. Read information in full:
Thursday 11th June 2026



